View drug registration information details.
Items | Registration information |
ID | 645 |
No | 645 |
Brand Name | ZYLTAN H |
Ingredients | LOSARTAN POTASSIUM USP 50 MG, HYDROCHLOROTHIAZIDE USP 12.5 MG |
Dosage Form | FILM COATED TABLET |
Primary Packaging | ALU-ALU BLISTER |
Storage | STORE BELOW 30 C, PROTECT FROM LIGHT |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 3 X 10 TABLETS |
Dispensing Category | PRESCRIPTION |
ATC Classification | |
Pharmaceutical Class | ANTI HYPERTENSIVE |
Indications | TREATMENT OF HYPERTENSION IN PATIENTS REQUIRING BOTH LOSARTAN AND HYDROCHLOROTHIAZIDE. |
Contraindications | HYPERSENSITIVITY, ANURIA |
Side Effects | MUSCLE CRAMPS, BACK PAIN, LEG PAIN, DIZZINESS, NASAL CONGESTION, SINUSITIS, ASTHENIA, EDEMA, ABDOMINAL PAIN, CHEST PAIN, NAUSEA, HEADACHE, DIARRHEA, MYALGIA, INSOMNIA, COUGH, SINUS DISORDER |
Unit Price | |
EDL |
No |
Description | REDDISH BROWN COLORED, OBLONG SHAPED, FILM COATED TABLET HAVING A BREAK LINE ON ONE SIDE |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | TROIKAA PHARMACEUTICALS LIMITED |
Country | INDIA |
Import Registration No | 37/UA/2006 |
Import Registration Date | 2016-08-02 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2024-03-15 |
FDD Registration No | 05 I 5102/21 |
FDD Registration Date | 2024-04-08 |
Expiry Date | 2027-04-07 |
Back to drug list
|